Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial
Allergology International · 2026-06
DOI: 10.1016/j.alit.2026.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergology International, 2026-06. Verfasst von Tair Nurpeissov und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center Rakhat, Almaty, Kazakhstan; Department of General Immunology, Asfendiyarov Kazakh National Medical University (KazNMU), Almaty, Kazakh…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Center Rakhat, Almaty, Kazakhstan; Department of General Immunology, Asfendiyarov Kazakh National Medical University (KazNMU), Almaty, Kazakhstan.
- International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan; Laboratory of Preclinical and Experimental Studies, Kazakh National Agrarian Research University (KazNARU…
- Medical Center Rakhat, Almaty, Kazakhstan.
- International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU), Almaty, Kazakhstan.
- Scientific Research Institute for Biological Safety Problems, Gvardeyskiy, Korday district, Zhambyl region, Kazakhstan.
- OtarBioPharm LLP, Gvardeyskiy, Korday district, Zhambyl region, Kazakhstan.
Zitieren
APA
Nurpeissov, T., Tabynov, K., Zhubanturliyeva, A., Nurpeissov, T., Khan, V., Seidakhmetov, O., Yessimova, B., Sarsenbayeva, G., Tailakova, E., Bolatbekov, T., Sergazina, A., Akhtemova, N., Rakhmatullayeva, G., Yelchibayeva, L., Shorayeva, K., Yershebulov, Z., Petrovsky, N., & Tabynov, K. (2026). Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial. Allergology International. https://doi.org/10.1016/j.alit.2026.05.010
Vancouver
Nurpeissov T, Tabynov K, Zhubanturliyeva A, Nurpeissov T, Khan V, Seidakhmetov O, et al. Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial. Allergology International. 2026. doi:10.1016/j.alit.2026.05.010
BibTeX
@article{Nurpeissov2026,
author = {Nurpeissov, Tair and Tabynov, Kairat and Zhubanturliyeva, Ainagul and Nurpeissov, Temyrzhan and Khan, Viktoriya and Seidakhmetov, Olzhas and Yessimova, Baktygul and Sarsenbayeva, Gulbanu and Tailakova, Elmira and Bolatbekov, Turlan and Sergazina, Akbota and Akhtemova, Nazugum and Rakhmatullayeva, Guliza and Yelchibayeva, Leila and Shorayeva, Kamshat and Yershebulov, Zakir and Petrovsky, Nikolai and Tabynov, Kaissar},
title = {Ultra-short recombinant Art v 1 immunotherapy induces rapid immune modulation in mugwort allergy: A Phase I trial},
journal = {Allergology International},
year = {2026},
doi = {10.1016/j.alit.2026.05.010}
}
EUVIMED